JPWO2020222302A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020222302A5 JPWO2020222302A5 JP2021517161A JP2021517161A JPWO2020222302A5 JP WO2020222302 A5 JPWO2020222302 A5 JP WO2020222302A5 JP 2021517161 A JP2021517161 A JP 2021517161A JP 2021517161 A JP2021517161 A JP 2021517161A JP WO2020222302 A5 JPWO2020222302 A5 JP WO2020222302A5
- Authority
- JP
- Japan
- Prior art keywords
- citric acid
- mixture
- hydrate
- acceptable salt
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 64
- 229960004106 citric acid Drugs 0.000 claims 20
- 239000000203 mixture Substances 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 10
- -1 or a hydrate thereof Substances 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 4
- 208000007502 anemia Diseases 0.000 claims 3
- 229960000999 sodium citrate dihydrate Drugs 0.000 claims 3
- 229960004543 anhydrous citric acid Drugs 0.000 claims 2
- CAQZHWGBHJFEGM-UHFFFAOYSA-L dipotassium 3-carboxy-3,5-dihydroxy-5-oxopentanoate hydroxide Chemical compound C(CC(O)(C(=O)O)CC(=O)O)(=O)[O-].[K+].[OH-].[K+] CAQZHWGBHJFEGM-UHFFFAOYSA-L 0.000 claims 2
- PJAHUDTUZRZBKM-UHFFFAOYSA-K potassium citrate monohydrate Chemical compound O.[K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PJAHUDTUZRZBKM-UHFFFAOYSA-K 0.000 claims 2
- 229940050931 potassium citrate monohydrate Drugs 0.000 claims 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 claims 1
- 206010058116 Nephrogenic anaemia Diseases 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019086945 | 2019-04-28 | ||
| JP2019119297 | 2019-06-27 | ||
| PCT/JP2020/017690 WO2020222302A1 (ja) | 2019-04-28 | 2020-04-24 | 新規医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2020222302A1 JPWO2020222302A1 (https=) | 2020-11-05 |
| JPWO2020222302A5 true JPWO2020222302A5 (https=) | 2022-02-01 |
Family
ID=73028960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517161A Pending JPWO2020222302A1 (https=) | 2019-04-28 | 2020-04-24 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220202752A1 (https=) |
| EP (1) | EP3964264A4 (https=) |
| JP (1) | JPWO2020222302A1 (https=) |
| KR (1) | KR20220004643A (https=) |
| AU (1) | AU2020267068A1 (https=) |
| CA (1) | CA3137691A1 (https=) |
| WO (1) | WO2020222302A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7219898B2 (ja) * | 2017-04-18 | 2023-02-09 | 国立大学法人東北大学 | アルカリ性化剤による血液浄化 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4722492B2 (ja) * | 2005-01-11 | 2011-07-13 | 日本メナード化粧品株式会社 | 鉄欠乏性貧血に伴う不定愁訴の予防又は改善剤。 |
| JP2009525277A (ja) * | 2006-01-30 | 2009-07-09 | グロボアジア エルエルシー | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| EP2194977A1 (en) * | 2007-08-31 | 2010-06-16 | C.B. Fleet Company Incorporated | Method of preventing nephrocalcinosis |
| MX357998B (es) * | 2015-03-20 | 2018-07-11 | Antonio Hernandez Miramontes Jorge | Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo. |
| CA3010771A1 (en) * | 2016-01-06 | 2017-07-13 | Rockwell Medical, Inc. | Combination therapy with an iron compound and a citrate compound |
| WO2018193648A1 (ja) | 2017-04-18 | 2018-10-25 | 国立大学法人東北大学 | アルカリ性化剤による血液浄化 |
| JP7578234B2 (ja) * | 2017-04-18 | 2024-11-06 | 国立大学法人東北大学 | アルカリ性化剤による血液浄化 |
| JP6296410B1 (ja) | 2017-11-06 | 2018-03-20 | 株式会社ＤａｔａＳｉｇｎ | 利用サービス管理装置 |
| JP6810683B2 (ja) | 2017-12-28 | 2021-01-06 | 本田技研工業株式会社 | 制御装置および車両 |
| AU2019361520B2 (en) * | 2018-10-17 | 2025-04-24 | Nippon Chemiphar Co., Ltd. | Novel pharmaceutical composition |
-
2020
- 2020-04-24 CA CA3137691A patent/CA3137691A1/en active Pending
- 2020-04-24 US US17/606,125 patent/US20220202752A1/en not_active Abandoned
- 2020-04-24 JP JP2021517161A patent/JPWO2020222302A1/ja active Pending
- 2020-04-24 KR KR1020217034629A patent/KR20220004643A/ko not_active Ceased
- 2020-04-24 WO PCT/JP2020/017690 patent/WO2020222302A1/ja not_active Ceased
- 2020-04-24 EP EP20799485.6A patent/EP3964264A4/en not_active Withdrawn
- 2020-04-24 AU AU2020267068A patent/AU2020267068A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020138981A5 (https=) | ||
| JP2021504423A5 (https=) | ||
| JP2017513836A5 (https=) | ||
| JP2019517542A5 (https=) | ||
| JP2011105739A5 (https=) | ||
| JP2015529234A5 (https=) | ||
| PH12015500313A1 (en) | Orally administered medical composition | |
| JP2015536964A5 (https=) | ||
| RU2019134558A (ru) | Композиции и способы лечения анемии | |
| JP2015038135A5 (https=) | ||
| JP2023550149A5 (https=) | ||
| JP2023516951A5 (https=) | ||
| JP2017508817A5 (https=) | ||
| JP2012512164A5 (https=) | ||
| JP2019533660A5 (https=) | ||
| JP2016502981A5 (https=) | ||
| JP2021529829A5 (https=) | ||
| JPWO2020222302A5 (https=) | ||
| JP2019504024A5 (https=) | ||
| JP2006524699A5 (https=) | ||
| JP2017508004A5 (https=) | ||
| RU2018119085A (ru) | Схема введения ингибитора фосфатидилинозитол-3-киназы | |
| JP5865903B2 (ja) | 経口鉄欠乏療法 | |
| KR20230027157A (ko) | 바다두스타트의 약물-약물 상호작용의 조절 | |
| ITMI20071979A1 (it) | Formulazioni farmaceutiche contenenti ferro bisglicinato chelato |